Annual Total Debt
$210.14 M
+$3.04 M+1.47%
December 31, 2023
Summary
- As of February 8, 2025, INBX annual total debt is $210.14 million, with the most recent change of +$3.04 million (+1.47%) on December 31, 2023.
- During the last 3 years, INBX annual total debt has risen by +$172.69 million (+461.06%).
- INBX annual total debt is now at all-time high.
Performance
INBX Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$1.83 M
-$336.00 K-15.48%
September 30, 2024
Summary
- As of February 8, 2025, INBX quarterly total debt is $1.83 million, with the most recent change of -$336.00 thousand (-15.48%) on September 30, 2024.
- Over the past year, INBX quarterly total debt has dropped by -$336.00 thousand (-15.48%).
- INBX quarterly total debt is now -99.12% below its all-time high of $209.38 million, reached on September 30, 2023.
Performance
INBX Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
INBX Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.5% | -15.5% |
| 3 y3 years | +461.1% | -99.1% |
| 5 y5 years | +2113.4% | -99.1% |
INBX Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +172.3% | -99.1% | at low |
| 5 y | 5-year | at high | +461.1% | -99.1% | -100.0% |
| alltime | all time | at high | +2113.4% | -99.1% | -100.0% |
Inhibrx Biosciences Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.83 M(-15.5%) |
| Jun 2024 | - | $2.17 M(-18.9%) |
| Mar 2024 | - | $2.68 M(-15.6%) |
| Dec 2023 | $210.14 M(+1.5%) | $3.17 M(-98.5%) |
| Sep 2023 | - | $209.38 M(+0.4%) |
| Jun 2023 | - | $208.61 M(+0.4%) |
| Mar 2023 | - | $207.85 M(+0.4%) |
| Dec 2022 | $207.10 M(+168.3%) | $207.10 M(+17.5%) |
| Sep 2022 | - | $176.29 M(+0.3%) |
| Jun 2022 | - | $175.70 M(+52.2%) |
| Mar 2022 | - | $115.45 M(+49.6%) |
| Dec 2021 | $77.18 M | $77.18 M(+0.0%) |
| Sep 2021 | - | $77.17 M(+0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $77.15 M(+106.9%) |
| Mar 2021 | - | $37.30 M(-0.4%) |
| Dec 2020 | $37.45 M(-10.3%) | $37.45 M(+231.9%) |
| Sep 2020 | - | $11.28 M(+4.7%) |
| Jun 2020 | - | $10.78 M(>+9900.0%) |
| Mar 2020 | - | $0.00(-100.0%) |
| Dec 2019 | $41.73 M(+339.6%) | $41.73 M(>+9900.0%) |
| Sep 2019 | - | $0.00(-100.0%) |
| Jun 2019 | - | $40.42 M(+142.9%) |
| Mar 2019 | - | $16.64 M(>+9900.0%) |
| Dec 2018 | $9.49 M(-35.2%) | - |
| Jun 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00 |
| Dec 2017 | $14.66 M | - |
FAQ
- What is Inhibrx Biosciences annual total debt?
- What is the all time high annual total debt for Inhibrx Biosciences?
- What is Inhibrx Biosciences annual total debt year-on-year change?
- What is Inhibrx Biosciences quarterly total debt?
- What is the all time high quarterly total debt for Inhibrx Biosciences?
- What is Inhibrx Biosciences quarterly total debt year-on-year change?
What is Inhibrx Biosciences annual total debt?
The current annual total debt of INBX is $210.14 M
What is the all time high annual total debt for Inhibrx Biosciences?
Inhibrx Biosciences all-time high annual total debt is $210.14 M
What is Inhibrx Biosciences annual total debt year-on-year change?
Over the past year, INBX annual total debt has changed by +$3.04 M (+1.47%)
What is Inhibrx Biosciences quarterly total debt?
The current quarterly total debt of INBX is $1.83 M
What is the all time high quarterly total debt for Inhibrx Biosciences?
Inhibrx Biosciences all-time high quarterly total debt is $209.38 M
What is Inhibrx Biosciences quarterly total debt year-on-year change?
Over the past year, INBX quarterly total debt has changed by -$336.00 K (-15.48%)